Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. [electronic resource]
- International journal of pharmaceutics Oct 2017
- 577-587 p. digital
Publication Type: Journal Article
1873-3476
10.1016/j.ijpharm.2017.05.030 doi
Antitubercular Agents--administration & dosage Drug Carriers--chemistry Drug Combinations Ethionamide--administration & dosage Hydroxamic Acids--administration & dosage Nanoparticles--chemistry Triazoles--administration & dosage beta-Cyclodextrins--chemistry